Live News EQUITY FLASH L impact Oct 30, 2026, 07:53 AM UTC Goldman Sachs Maintains Buy Rating on InnoCare Pharma Goldman Sachs maintained its Buy rating on InnoCare Pharma. SquawkNews Desk